Who are the top Indian imipenem exporters/manufacturers?

The top Indian imipenem exporters in 2025-Q4 include VENUS REMEDIES LTD. 19 Indian companies exported imipenem to 26 countries, with total trade value of $1.5M. This report ranks all 19 suppliers by trade value with detailed profiles.

What is the price of Indian imipenem exports?

Indian imipenem export prices vary by dosage form, destination, and volume. This report provides median prices, price distribution (P5-P95), supplier-level pricing, and a country-by-dosage price matrix — based on 45 real customs shipments.

How to find Indian imipenem suppliers/manufacturers?

This free report lists all 19 Indian imipenem manufacturers/exporters ranked by trade value, with city, dosage forms, destination countries, and buyer portfolios. Top suppliers get 2-page profiles with trade flow maps.

PHARMA TRADE INTELLIGENCE

INDIA EXPORT INTELLIGENCE REPORT

Imipenem

2025-Q4

Comprehensive analysis of India’s imipenem export trade — suppliers, buyers, prices, routes, and every shipment record.

45

Shipments

$1.48M

Trade Value

19

Suppliers

26

Buyers

26

Countries

Scan for online report

Talk to our analyst: +91 95950 78788

https://transdatanexus.com/pharmaceutical/imipenem

01

PART I — OVERVIEW

Executive Summary

At-a-glance KPIs, key findings, and strategic positioning of India’s imipenem trade — 2025-Q4

KEY TAKEAWAY Imipenem 2025-Q4 exports total $1.5M across 26 countries, with VENUS REMEDIES LTD commanding 42.8% market share.

TOTAL SHIPMENTS

45

2025-Q4

EXPORT VALUE

$1.5M

FOB USD

TOTAL QUANTITY

905.2K

units shipped

INDIAN SUPPLIERS

19

unique exporters

GLOBAL BUYERS

26

unique importers

DESTINATIONS

26

countries

MEDIAN UNIT PRICE

$2.19

per unit

TOP-5 SHARE

92.6%

of total USD

BRANDED SHARE

53.3%

24 shipments

DOSAGE FORMS

7

product types

6 KEY FINDINGS

1

VENUS REMEDIES LTD is India's #1 Imipenem exporter with $631.5K (42.8% market share).→ §5, Indian Supplier Rankings

2

Imipenem reached 26 countries, with Mexico as the top destination ($414.0K).→ §4, Global Destination Map

3

Market concentration is high (HHI: 3524) — top 10 suppliers control 98.3% of exports.→ §5, Indian Supplier Rankings

4

92.3% of buyers (24 of 26) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings

5

Injection dominates (68.9%) across 7 dosage forms.→ §7, Price Benchmarks

6

26 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities

WHO THIS REPORT IS FOR

S SUPPLIERS (Indian pharma exporters)

See which buyers your competitors are shipping to, at what price, through which ports
Identify buyers that are single-sourced (poaching opportunities)
Benchmark your pricing and catalog vs the Top 25

B BUYERS (global importers)

Discover which Indian exporters supply this product and what they sell
Benchmark the price you are paying vs the market median by country and dosage
Identify alternative suppliers with proven exports to similar destinations

Figure 1.1 VENUS REMEDIES LTD leads in volume — how do 19 exporters compare on price × volume?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Every bubble is one Indian imipenem exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.

HOW TO READ THIS REPORT

60 seconds

Scan this page — KPIs, thesis, flagship chart, top findings

5 minutes

Read every Key Takeaway line across §1–§9

30 minutes

Read sections tagged for your role ([S] or [B]) end-to-end

In depth

Drill into §10 for your country · supplier / buyer directories at end

02

PART I — OVERVIEW

About This Report

Data sources, methodology, trust signals, and what this Imipenem report covers

KEY TAKEAWAY Every figure in this report is grounded in real commercial imipenem trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.

S FOR SUPPLIERS

Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.

B FOR BUYERS

Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian imipenem suppliers.

§2.1 Reporting parameters · the scope of this 2025-Q4 Imipenem India trade report

P

Product scope

Imipenem

All variants merged — branded and generic formulations of imipenem

T

Time period

2025-Q4

October, November, December 2025 — a single-quarter snapshot

S

Data sources

Official & public trade records

Government customs filings, public trade databases and licensed commercial feeds

G

Geography

India origin → global

Indian sea and air ports shipping to destination markets worldwide

C

Currency

USD (FOB)

Declared Free-on-Board value at the Indian port of loading

R

Shipments analysed

45

Every commercial imipenem trade record in the period, aggregated and deduplicated

§2.2 Our quality process · Figure 2.1

Figure 2.1 From raw trade records to a clean report — the four quality pillars.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.

§2.3 Trust signals · what you can rely on in the numbers you read

DATA COVERAGE

10M+

Pharmaceutical trade records across the full TransData Nexus platform.

COUNTRIES

150+

Origin and destination countries covered in the global pharma trade database.

DATA ACCURACY

99.9%

Validation rate on core fields — supplier, buyer, product, quantity, value.

UPDATE FREQUENCY

Daily

Platform refresh cadence. This report is a snapshot from the same live data.

§2.4 Limitations · what the data does and does not tell you

WHAT THIS DATA DOES AND DOES NOT SAY

Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.

03

PART II — MARKET STRUCTURE

Quarterly Trade Overview

Monthly trends, regional performance, and ranking shifts — 2025-Q4

KEY TAKEAWAY 2025-Q4 followed a mixed: Oct $439.6K, Nov $522.3K, Dec $513.7K. Shipment counts rose across the quarter.

S FOR SUPPLIERS

Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.

B FOR BUYERS

Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.

1

$439.6K

Oct USD

5 shipments

2

$522.3K

Nov USD

+18.8% MoM

3

$513.7K

Dec USD

-1.6% MoM

4

Mixed

Q4 growth shape

Oct → Nov → Dec

Fig 3.1 Nov rose 18.8% in USD but shipment count kept climbing.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $440K, making it the weakest month by value.

Fig 3.2 Q4 cumulative USD reached $1.5M.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.

Fig 3.3 $83K rise in Nov, $9K decline in Dec.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.

Fig 3.4 Regional breakdown by month — which corridors swung most?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.

§3.1 Monthly summary

Oct	$440K	5 shipments
Nov	$522K	23 shipments
Dec	$514K	17 shipments
Q4 Total	$1.5M	45 shipments

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Belgium held #1 throughout the quarter.

Fig 3.6 Top 10 Indian exporters by monthly USD rank.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SUN PHARMACEUTICAL INDUSTRIES LTD maintained its leading position.

04

PART II — MARKET STRUCTURE

Global Destination Map

Which countries import imipenem from India, how much they buy, and who supplies each market

KEY TAKEAWAY Mexico absorbs 28.1% of India’s 2025-Q4 imipenem trade ($414.0K). Beyond the top 10 destinations, 26 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 9 destination countries, the widest regional diversity.

S FOR SUPPLIERS

Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 26 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.

B FOR BUYERS

Find your country on the map to see how much imipenem India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.

Asia

$253K

17.2% of trade

9 countries · 15 shipments

Europe

$629K

42.6% of trade

5 countries · 10 shipments

Americas

$505K

34.2% of trade

5 countries · 8 shipments

Africa

$88K

6.0% of trade

7 countries · 12 shipments

Fig 4.1 Mexico is the #1 corridor ($414K) — 26 flow arcs from India radiate across 4 continents.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The world map shows every country colored by how much Indian imipenem it receives (light = low, dark = high). Orange arcs radiate from India to the top 26 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

#	Destination	Total USD	Ships	#1 Indian supplier	USD	#2 Indian supplier	USD	#3 Indian supplier	USD
1	Mexico	$414K	4	VENUS REMEDIES LTD	$414K	—	—	—	—
2	Belgium	$365K	5	SUN PHARMACEUTICAL INDUSTRIES LTD	$365K	—	—	—	—
3	Netherlands	$203K	2	SUN PHARMACEUTICAL INDUSTRIES LTD	$203K	—	—	—	—
4	Saudi Arabia	$150K	3	VENUS REMEDIES LTD	$150K	—	—	—	—
5	Bolivia	$65K	1	KWALITY PHARMACEUTICALS LTD	$65K	—	—	—	—
6	Nepal	$51K	3	ALKEM LABORATORIES LTD	$35K	M. J. BIOPHARM PVT LTD	$16K	—	—
7	Madagascar	$35K	1	G S PHARMA PVT LTD	$35K	—	—	—	—
8	Hong Kong	$28K	1	VENUS REMEDIES LTD	$28K	—	—	—	—
9	Albania	$28K	1	NOVO MEDI SCIENCES PVT LTD	$28K	—	—	—	—
10	Hungary	$24K	1	VENUS REMEDIES LTD	$24K	—	—	—	—

Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.

Fig 4.2 Asia leads at 17.2% of USD — but Mexico is the single largest market.

Region → country treemap

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.

§4.2 Destination concentration

28.1%

#1 country share

Mexico alone

81.2%

Top 5 share

5 of 26 countries

98.1%

Top 15 share

Long tail of 11 countries = 1.9%

HHI 1748

Destination HHI

Moderately concentrated

26

Countries served

Global pharma reach from India

9

Asia countries

Widest regional diversity

Source: TransData Nexus trade data platform

05

PART III — WHO’S IN THIS MARKET

Indian Supplier Rankings & Profiles

19 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence

KEY TAKEAWAY VENUS REMEDIES LTD ($631.5K, 42.8% share) and SUN PHARMACEUTICAL INDUSTRIES LTD ($600.1K) together control 83.5% of India’s 2025-Q4 imipenem trade. The top 5 suppliers hold 92.6%. 19 companies shipped at least once.

S FOR SUPPLIERS

Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.

B FOR BUYERS

Find potential Indian imipenem suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.

Fig 5.1 VENUS REMEDIES LTD leads by $31K over SUN PHARMACEUTICAL INDUSTRIES LTD — top 19 Indian exporters ranked by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MDS ENTERPRISES is #18 by value but #5 by volume.

Fig 5.2 VENUS REMEDIES LTD also leads by shipment count (14) but ranking shifts for volume-heavy players

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MDS ENTERPRISES moves from #5 by volume to #18 by value — fewer but higher-value shipments.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — Archetypes & Concentration

How India’s 19 imipenem suppliers split into strategic segments

KEY TAKEAWAY 5 suppliers (25%) generate 92.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.

Fig 5.3 VENUS REMEDIES LTD and SUN PHARMACEUTICAL INDUSTRIES LTD sit in the leaders zone — high volume AND high value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.

Fig 5.4 25% of suppliers = 92.6% of USD — classic concentration.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.

Product variety — how many formulations each supplier ships

#	Supplier	Dosage forms	Countries	USD
1	VENUS REMEDIES LTD	4	7	$631K
2	SUN PHARMACEUTICAL INDUSTRIES LTD	4	5	$600K
3	KWALITY PHARMACEUTICALS LTD	1	1	$65K
4	ALKEM LABORATORIES LTD	1	1	$35K
5	G S PHARMA PVT LTD	1	1	$35K
6	NOVO MEDI SCIENCES PVT LTD	1	1	$28K
7	CHETAN & DIPTI (C&D) PHARMA PVT LTD	1	1	$18K
8	M. J. BIOPHARM PVT LTD	1	1	$16K
9	FLAGSHIP BIOTECH INTERNATIONAL PVT LTD	1	1	$11K
10	INDUS PHARMA PVT LTD	1	1	$11K

Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — India Origin Geography & Concentration

Which Indian cities and states are the imipenem manufacturing hubs

KEY TAKEAWAY Behra and Mumbai together account for $1.1M of India’s 2025-Q4 imipenem trade.

Fig 5.5 Behra (1 exporters, $631K) and Mumbai (8 exporters, $501K) are India’s imipenem capitals.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.

§5.1 Supplier concentration metrics

92.6%

Top 5 share

5 of 19 suppliers

98.3%

Top 10 share

10 of 19 suppliers

92.6%

Top 25% share

5 suppliers = 93% USD

HHI 3524

Supplier HHI

Concentrated

19

Total suppliers

shipped Imipenem in 2025-Q4

14+ cities

Indian hubs

Behra and Mumbai lead

§5.2 Coming next: 2 exporter deep-dive profiles

Each of the top 2 suppliers gets a dedicated 2-page profile with:

6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
Dosage form breakdown — what formulations they ship
Monthly trend — Oct / Nov / Dec trajectory
Trade flow map — supplier → country → importer connections
Buyer portfolio with lock-in analysis

SUPPLIER PROFILES IN THIS REPORT

#1	VENUS REMEDIES LTD	$631K
#2	SUN PHARMACEUTICAL INDUSTRIES LTD	$600K

#1

EXPORTER PROFILE #1 OF 2

VENUS REMEDIES LTD

Behra · India’s #1 imipenem supplier by USD · 2025-Q4

2025-Q4 USD

$631K

42.8% market share

SHIPMENTS

14

avg $45K/ship

COUNTRIES

7

destination markets

BUYERS

9

8 single-sourced

BRANDED

71%

of shipments

DOSAGE FORMS

4

product types

TOP 7 DESTINATIONS

Mexico is the #1 market at $414K (66% of trade), followed by Saudi Arabia at $150K. 7 countries served.

#	Country	USD	Ships	Share
1	Mexico	$414K	4	65.6%
2	Saudi Arabia	$150K	3	23.8%
3	Hong Kong	$28K	1	4.5%
4	Hungary	$24K	1	3.8%
5	Jamaica	$14K	1	2.3%
6	South Africa	$665	1	0.1%
7	Morocco	$5	3	0.0%

MONTHLY TREND

Oct peaked at $359K. Dec was the weakest at $33K.

PRODUCT MIX

Injection dominates at 67% of trade. Powder (28.3%) and Oral Solution are secondary formulations.

Injection

67.2%

Powder

28.3%

Oral Solution

3.8%

Solution

0.6%

Unknown

0.0%

TOP BUYERS · 8/8 LOCKED IN

8 of 8 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
L J S A D E C V	Mexico	$359K	⚠ Locked
S T C	Saudi Arabia	$150K	⚠ Locked
L J S D C	Mexico	$54K	⚠ Locked
C P L	Hong Kong	$28K	⚠ Locked
E P H K	Hungary	$24K	⚠ Locked
MEDICAL PRODUCTS LTD	Jamaica	$14K	⚠ Locked
U L G	South Africa	$665	⚠ Locked
PHARMAPROM	Morocco	$5	⚠ Locked
Undisclosed buyer	Morocco	$0	N/A

#1

EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP

VENUS REMEDIES LTD — Supplier → Country → Importer

5 destination countries, top 5 importers per country

Fig 5.P1.3 Mexico absorbs $414K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.

#2

EXPORTER PROFILE #2 OF 2

SUN PHARMACEUTICAL INDUSTRIES LTD

Andheri Kurla Road · India’s #2 imipenem supplier by USD · 2025-Q4

2025-Q4 USD

$600K

40.7% market share

SHIPMENTS

10

avg $60K/ship

COUNTRIES

5

destination markets

BUYERS

5

4 single-sourced

BRANDED

30%

of shipments

DOSAGE FORMS

4

product types

TOP 5 DESTINATIONS

Belgium is the #1 market at $365K (61% of trade), followed by Netherlands at $203K. 5 countries served.

#	Country	USD	Ships	Share
1	Belgium	$365K	5	60.9%
2	Netherlands	$203K	2	33.8%
3	South Africa	$18K	1	3.0%
4	Kenya	$14K	1	2.3%
5	Brazil	$3	1	0.0%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $373K.

PRODUCT MIX

Injection dominates at 64% of trade. Powder (33.8%) and Vial are secondary formulations.

Injection

63.9%

Powder

33.8%

Vial

2.3%

Suspension

0.0%

TOP BUYERS · 4/4 LOCKED IN

4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
YUSEN LOGISTICS BENELU…	Belgium	$219K	⚠ Locked
I+SOLUTIONS	Netherlands	$203K	⚠ Locked
Undisclosed buyer	Belgium	$160K	N/A
RANBAXY PHARMACEUTICAL…	South Africa	$18K	⚠ Locked
RANBAXY FARMACEUTICA L…	Brazil	$3	⚠ Locked

#2

EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP

SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer

5 destination countries, top 5 importers per country

Fig 5.P2.3 Belgium absorbs $365K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.

06

PART III — WHO’S IN THIS MARKET

Global Buyer Rankings & Intelligence

26 importers across 26 countries — who is buying Indian imipenem and how much

KEY TAKEAWAY The demand side is dramatically more fragmented than supply: the top 24 importers together hold only 85.8% of total USD. 92% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.

S FOR SUPPLIERS

Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).

B FOR BUYERS

See where you rank among global importers of Indian imipenem. Compare your USD and shipment count against peers in your country and dosage segment.

Fig 6.1 L J S A D E C V is the #1 importer at $359K (24.4%) — top 24 by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one global importer ranked by USD.

Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same 24 importers re-ranked by shipment count.

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

92%

Single-source

24 buyers rely on exactly 1 Indian supplier

0%

Dual-source

0 buyers use 2 Indian suppliers

4%

Multi-source (3–4)

1 buyers diversified across 3–4

4%

Broad-source (5+)

1 buyers with 5+ Indian suppliers

06

PART III — WHO’S IN THIS MARKET

Single-Source Buyers & Price Benchmark

Lock-in opportunities grouped by country + where each buyer sits on the price spectrum

KEY TAKEAWAY These importers source imipenem from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.

S FOR SUPPLIERS

This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.

B FOR BUYERS

If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.

§6.2 Single-source lock-in by country

Mexico 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
L J S A D E C V	VENUS REMEDIES LTD	$359K	$1.605	Injection
L J S D C	VENUS REMEDIES LTD	$54K	$0.209	Injection

Nepal 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
PARTH PHARMA DISTRIBUT…	ALKEM LABORATORIES LTD	$35K	$0.347	Injection
S GENERIX PHARMA DISTR…	M. J. BIOPHARM PVT LTD	$16K	$2.207	Injection

South Africa 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
RANBAXY PHARMACEUTICAL…	SUN PHARMACEUTICAL I…	$18K	$2.258	Injection
U L G	VENUS REMEDIES LTD	$665.410	$0.033	Powder

Afghanistan 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
KHALIQ ZAZAI PVT LTD	INDUS PHARMA PVT LTD	$11K	$2.191	Injection
ETEMED MOSLEH LTD	RESCUERS LIFE SCIENC…	$9K	$1.713	Injection

Belgium 1 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
YUSEN LOGISTICS BENELU…	SUN PHARMACEUTICAL I…	$219K	$8.213	Injection

§6.3 Price positioning — top 24 importers

#	Importer	Country	USD	$/ship	Tier
1	L J S A D E C V	Mexico	$359K	$359K	Premium
2	YUSEN LOGISTICS BENE…	Belgium	$219K	$73K	Premium
3	I+SOLUTIONS	Netherlands	$203K	$102K	Premium
4	S T C	Saudi Arabia	$150K	$50K	Premium
5	LOBA IMPORT EXPORT SRL	Bolivia	$65K	$65K	Premium
6	L J S D C	Mexico	$54K	$18K	Mid
7	PARTH PHARMA DISTRIB…	Nepal	$35K	$18K	Mid
8	LA COOPERATION PHARM…	Madagascar	$35K	$35K	Mid
9	C P L	Hong Kong	$28K	$28K	Mid
10	E P H K	Hungary	$24K	$24K	Mid
11	KAMCARE PHARMA LTD	Uganda	$18K	$9K	Budget
12	RANBAXY PHARMACEUTIC…	South Africa	$18K	$18K	Mid
13	S GENERIX PHARMA DIS…	Nepal	$16K	$16K	Mid
14	MEDICAL PRODUCTS LTD	Jamaica	$14K	$14K	Budget
15	KHALIQ ZAZAI PVT LTD	Afghanistan	$11K	$11K	Budget
16	ETEMED MOSLEH LTD	Afghanistan	$9K	$9K	Budget
17	OFFICE PHARMACEUTIQU…	Gabon	$2K	$2K	Budget
18	GULF PHARMACIES W.L.L	Bahrain	$2K	$2K	Budget
19	U L G	South Africa	$665.410	$665.000	Budget
20	TO THE IMPORTING DEP…	Singapore	$204.100	$204.000	Budget
21	FOR THE ORDER OF	Kenya	$139.597	$140.000	Budget
22	OCTELLE CO LTD	Myanmar	$9.983	$10.000	Budget
23	PHARMAPROM	Morocco	$4.573	$2.000	Budget
24	RANBAXY FARMACEUTICA…	Brazil	$2.665	$3.000	Budget

06

PART III — WHO’S IN THIS MARKET

Market Relationship Map

The top 19 × 20 supplier ↔ buyer network as a circular flow diagram

Fig 6.3 VENUS REMEDIES LTD → L J S A D E C V is the strongest relationship.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left semicircle = top 19 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

How Indian imipenem prices vary by supplier, country and dosage form

KEY TAKEAWAY Imipenem prices span 21551× ($0.0010 → $21.02). The coefficient of variation is 1.49. Dosage form, not destination, is the primary price driver.

S FOR SUPPLIERS

Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.

B FOR BUYERS

Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.

§7.1 Price distribution · Table 7.1

Statistic	Value	Interpretation
Min	$0.0010	Lowest observed unit price
P5	$0.018	5th percentile
P25	$0.200	25th percentile (Q1)
Median	$2.19	50th percentile (Q2)
P75	$2.83	75th percentile (Q3)
P95	$17.22	95th percentile
Max	$21.02	Highest observed unit price
Mean	$3.44	Arithmetic average
CV	149%	Coefficient of variation (std/mean)

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 7.1 JPC GLOBAL prices at $10.21/unit vs market median $2.19.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).

COMMODITY KINGS

high volume · low unit price

Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. VENUS REMEDIES LTD Sourcing: best for cost-driven procurement.

BULK LEADERS

high volume · premium price

Branded-generic leaders, above-median pricing. e.g. SUN PHARMACEUTICAL INDUSTRIES Sourcing: hardest to displace; compete on relationship.

LONG-TAIL

low volume · low unit price

Spot/opportunistic players. Sourcing: first to approach for new tenders.

PREMIUM NICHE

low volume · premium price

Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage

KEY TAKEAWAY Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

↑ TOP 10 HIGHEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Dec 2025	SUN PHARMACEUTIC…	Belgium	Injection	5K	$111K	$21.02	Sterile formulation premium
Nov 2025	SUN PHARMACEUTIC…	Belgium	Injection	6K	$116K	$19.70	Sterile formulation premium
Dec 2025	SUN PHARMACEUTIC…	Belgium	Injection	3K	$58K	$17.40	Sterile formulation premium
Nov 2025	SUN PHARMACEUTIC…	Belgium	Injection	2K	$31K	$16.46	Sterile formulation premium
Dec 2025	JPC GLOBAL	Singapore	Injection	20	$204.10	$10.21	Sterile formulation premium
Nov 2025	MILTON LIFECARE …	Bahrain	Injection	400	$2K	$5.99	Sterile formulation premium
Nov 2025	SUN PHARMACEUTIC…	Kenya	Vial	3K	$14K	$4.54	Specialty / small-batch
Nov 2025	VENUS REMEDIES LTD	Jamaica	Injection	4K	$14K	$3.60	Sterile formulation premium
Nov 2025	CHETAN & DIPTI (…	Uganda	Injection	5K	$18K	$3.56	Sterile formulation premium
Nov 2025	VENUS REMEDIES LTD	Saudi Arabia	Powder	11K	$36K	$3.43	Specialty / small-batch

↓ TOP 10 LOWEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Nov 2025	SUN PHARMACEUTIC…	Brazil	Suspension	338	$2.67	$0.0079	Small sample / trial shipment
Dec 2025	VENUS REMEDIES LTD	Mexico	Solution	217K	$4K	$0.018
Dec 2025	VENUS REMEDIES LTD	Mexico	Injection	13K	$242.24	$0.018	Sterile formulation premium
Dec 2025	MDS ENTERPRISES	Ghana	Injection	500	$9.81	$0.020	Sterile formulation premium
Dec 2025	MDS ENTERPRISES	United Arab Emirates	Injection	500	$12.81	$0.026	Sterile formulation premium
Dec 2025	VENUS REMEDIES LTD	South Africa	Powder	20K	$665.41	$0.033
Nov 2025	VENUS REMEDIES LTD	Morocco	—	3	$0.114	$0.038	Small sample / trial shipment
Nov 2025	VENUS REMEDIES LTD	Morocco	Injection	20	$2.28	$0.114	Sterile formulation premium
Nov 2025	VENUS REMEDIES LTD	Morocco	—	20	$2.29	$0.115	Small sample / trial shipment
Nov 2025	ALKEM LABORATORI…	Nepal	Injection	31K	$6K	$0.191	Sterile formulation premium

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.

NEGOTIATION RANGE

Use each cell value as the anchor price. Typical dynamics:

Budget buyer: anchor − 10–15% (floor = cost + freight)
Mid-market: anchor ± 5–10%
Premium/tender: anchor + 10–25% (regulated, quality premium)
Injection/infusion: always 4–10× the tablet price

KEY TAKEAWAYS

Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Which Indian ports ship imipenem, which global ports receive it, and which corridors are high-value vs bulk

KEY TAKEAWAY Imipenem leaves India through 11+ ports. The top 5 (DADRI ICD, DELHI AIR, MUMBAI AIR (SAHAR)) handle 82.3% of total USD. ICD moves 20% of shipments.

S FOR SUPPLIERS

Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.

B FOR BUYERS

Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.

Fig 8.1 DADRI ICD handles $359K — top 11 Indian origin ports by trade value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.

Fig 8.2 Lazaro Cardenas is the #1 global destination port — top 25 by USD value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.

§8.1 Reference transit times for key India → global corridors

Route	Mode	Transit time	Notes
NHAVA SHEVA SEA (JNPT) → US East Coast	Sea	22–28 days	Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)	Sea	18–24 days	Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK	Air	3–5 days	Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam	Sea	20–26 days	Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow	Air	2–4 days	Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)	Sea	7–12 days	Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)	Road	1–2 days	Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)	Sea	14–20 days	Direct or via Colombo hub

Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Trade corridors — origin port to mode of transport to destination region

KEY TAKEAWAY ICD dominates at 20% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.

ICD

$694K

47.0% of USD · 20.0% of ships

AIR

$663K

45.0% of USD · 62.2% of ships

SEA

$68K

4.6% of USD · 11.1% of ships

ROAD

$51K

3.4% of USD · 6.7% of ships

Fig 8.3 The dominant corridor is DADRI ICD → Sea → N. America ($359K).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market concentration, supply-chain risk, and the dependency patterns that signal where to act

KEY TAKEAWAY Belgium is the most concentrated destination (HHI 10000, 1 suppliers). Afghanistan is the most competitive (HHI 5075).

S FOR SUPPLIERS

The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.

B FOR BUYERS

The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.

Fig 9.1 Belgium (HHI 10,000) is the most concentrated — Afghanistan (HHI 5,075) is the most competitive.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.

§9.1 Single-source dependencies

Buyer	Country	Sole supplier	USD	Ships	Risk
L J S A D E C V	Mexico	VENUS REMEDIES LTD	$359K	1	HIGH
YUSEN LOGISTICS BENE…	Belgium	SUN PHARMACEUTIC…	$219K	3	HIGH
I+SOLUTIONS	Netherlands	SUN PHARMACEUTIC…	$203K	2	HIGH
S T C	Saudi Arabia	VENUS REMEDIES LTD	$150K	3	HIGH
LOBA IMPORT EXPORT SRL	Bolivia	KWALITY PHARMACE…	$65K	1	MEDIUM
L J S D C	Mexico	VENUS REMEDIES LTD	$54K	3	MEDIUM
PARTH PHARMA DISTRIB…	Nepal	ALKEM LABORATORI…	$35K	2	MEDIUM
LA COOPERATION PHARM…	Madagascar	G S PHARMA PVT LTD	$35K	1	MEDIUM

Conclusion: 24 buyers depend on exactly one Indian supplier, representing $1.3M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.

§9.2 Multi-source resilience

Buyer	Country	Suppliers	USD	Dominant	Resilience

Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market entry playbook and risk landscape by destination country

KEY TAKEAWAY 15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).

§9.3 Sourcing recommendations · Table 9.1

Country	Tier	Lead	Price	Risk	Entry approach
Mexico	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Belgium	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Netherlands	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Saudi Arabia	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Bolivia	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Nepal	Tier 3 (emerging)	14–28 days (sea)	$0.10–$1/unit	LOW	First-mover advantage
Madagascar	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Hong Kong	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Albania	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Hungary	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Afghanistan	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
South Africa	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Uganda	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Jamaica	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Kenya	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage

For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.

Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.

09

PART V — ACTION

Action Plan & Easy-Entry Markets

12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers

KEY TAKEAWAY Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.

S

FOR SUPPLIERS

ID	Action	Timing	Impact
A1	Pitch top single-source buyer in Mexico	This Q	HIGH
A2	Offer alternative to top multi-source buyer	This Q	HIGH
A3	Audit Belgium lock-ins (HHI 10000)	This Q	MED
A5	Enter Mexico (1 suppliers)	This Q	HIGH
A6	Enter Belgium (1 suppliers)	This Q	MED
A8	Build Belgium distribution	6–12m	HIGH
A9	Bundle injection/infusion catalog for premium markets	6–12m	MED

B

FOR BUYERS

ID	Action	Timing	Impact
A4	Monitor rising exporters (climbers)	This Q	MED
A7	Register for Mexico tenders	6–12m	HIGH
A10	Track quarterly HHI shifts across key destinations	This Q	LOW
A11	Map competitor buyer portfolios quarterly	This Q	MED
A12	Qualify second source for single-source buyers	This Q	MED

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

#	Country	Region	Suppliers	Q4 USD	Growth	Barrier	Why this is easy
1	Mexico	Other	1	$414K	-98.8%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
2	Belgium	Other	1	$365K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
3	Netherlands	Other	1	$203K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
4	Saudi Arabia	Other	1	$150K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
5	Bolivia	Other	1	$65K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
6	Nepal	Asia	2	$51K	-100%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
7	Madagascar	Africa	1	$35K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
8	Hong Kong	Asia	1	$28K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
9	Albania	Other	1	$28K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
10	Hungary	Other	1	$24K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
11	Afghanistan	Asia	2	$20K	0%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
12	South Africa	Africa	2	$19K	0%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
13	Uganda	Africa	1	$18K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
14	Jamaica	Other	1	$14K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
15	Kenya	Africa	2	$14K	0%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry

This report covers 45 2025-Q4 Imipenem shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/imipenem

10

PART VI — EVIDENCE REGISTER

Comprehensive Shipment Records by Region

Authoritative source behind all analytics in this report — every shipment appears exactly once

KEY TAKEAWAY This section contains every one of the 45 2025-Q4 imipenem shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.

S FOR SUPPLIERS

Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.

B FOR BUYERS

Jump to your country to see every Indian imipenem shipment that arrived in 2025-Q4: supplier, price, dosage, port.

§10.1 Global totals

SHIPMENTS

45

across all regions

TOTAL USD

$1.48M

2025-Q4 FOB value

UNITS

905.2K

tablets, capsules, etc.

SUPPLIERS

19

Indian exporters

BUYERS

26

global importers

COUNTRIES

26

destinations

§10.2 Regional breakdown

Africa

$88K

6.0%

7 ctry · 12 ships

Asia

$253K

17.2%

9 ctry · 15 ships

Europe

$629K

42.6%

5 ctry · 10 ships

Americas

$505K

34.2%

5 ctry · 8 ships

§10.3 Key insights from the data

🌍

Africa is the largest region at $88K (6.0%), spanning 7 countries.

🏢

19 Indian suppliers shipped to 26 buyers across 26 countries — average shipment value $33K.

📄

Top 0 markets: .

🔍

Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.

§10.4 How to read a country page

1

6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.

2

4 mini-lists — top exporters, importers, dosages, monthly trend.

3

Shipment register — every row grouped by exporter. No row is duplicated or omitted.

10

PART VI — DRILL-DOWN · AFRICA

Region: Africa

7 countries · 12 shipments · $88K · 7 Indian suppliers · 9 buyers

SHIPMENTS

12

USD

$88K

COUNTRIES

7

SUPPLIERS

7

BUYERS

9

HHI

3,298

concentrated

Top 7 destination countries in Africa

1

Madagascar (39.6%)

$35K

2

South Africa (21.3%)

$19K

3

Uganda (20.6%)

$18K

4

Kenya (15.6%)

$14K

5

Gabon (2.8%)

$2K

6

Ghana (0.0%)

$9.81

7

Morocco (0.0%)

$4.69

Top 7 Indian suppliers into Africa

1

G S PHARMA PVT LTD

$35K

2

SUN PHARMACEUTICAL INDUSTRIES LTD

$32K

3

CHETAN & DIPTI (C&D) PHARMA PVT LTD

$18K

4

MEDNEXT BIOTECH LTD

$2K

5

VENUS REMEDIES LTD

$670.10

6

3S CORP

$139.60

7

MDS ENTERPRISES

$9.81

Top 7 Africa importers

1

LA COOPERATION PHARMACEUTIQUEMALGAC · Madagascar

$35K

2

KAMCARE PHARMA LTD · Uganda

$18K

3

RANBAXY PHARMACEUTICALS PTY LTD · South Africa

$18K

4

OFFICE PHARMACEUTIQUE NATIONALE · Gabon

$2K

5

U L G · South Africa

$665.41

6

FOR THE ORDER OF · Kenya

$139.60

7

PHARMAPROM · Morocco

$4.57

Top 5 dosage forms

1

Injection

$39K

2

Powder for Injection

$35K

3

Vial

$14K

4

Powder

$665.41

5

Unknown

$2.41

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$35K	$35K
Nov	8	$50K	$6K
Dec	3	$3K	$1K

Shipment register · 12 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — G S PHARMA PVT LTD · 1 shipments · $35K
1	Oct 2025	LA COOPERATION PHARMACEUTIQUEMALGAC	Madagascar	Powder for Injection	10.7K	NOS	$3.26	$35K	NHAVA SHEVA SEA (JNPT)	Toamasina	SEA
SUPPLIER #2 — SUN PHARMACEUTICAL INDUSTRIES LTD · 2 shipments · $32K
2	Nov 2025	RANBAXY PHARMACEUTICALS PTY LTD	South Africa	Injection	8.0K	PCS	$2.26	$18K	INDORE AIR	JOHANNESBURG - JOHAN	AIR
3	Nov 2025	UNKNOWN BUYER	Kenya	Vial	3.0K	PCS	$4.54	$14K	INDORE AIR	NAIROBI	AIR
SUPPLIER #3 — CHETAN & DIPTI (C&D) PHARMA PVT LTD · 2 shipments · $18K
4	Nov 2025	KAMCARE PHARMA LTD	Uganda	Injection	5.1K	NOS	$3.56	$18K	DELHI AIR	ENTEBBE	AIR
5	Nov 2025	KAMCARE PHARMA LTD	Uganda	Injection	560	NOS	$0.0010	$0.546	DELHI AIR	ENTEBBE	AIR
SUPPLIER #4 — MEDNEXT BIOTECH LTD · 1 shipments · $2K
6	Dec 2025	OFFICE PHARMACEUTIQUE NATIONALE	Gabon	Injection	1.0K	NOS	$2.50	$2K	NHAVA SHEVA SEA (JNPT)	Libreville	SEA
SUPPLIER #5 — VENUS REMEDIES LTD · 4 shipments · $670.10
7	Nov 2025	UNKNOWN BUYER	Morocco		3	NOS	$0.038	$0.114	DELHI AIR	CASABLANCA	AIR
8	Nov 2025	PHARMAPROM	Morocco	Injection	20	NOS	$0.114	$2.28	DELHI AIR	CASABLANCA	AIR
9	Nov 2025	PHARMAPROM	Morocco		20	NOS	$0.115	$2.29	DELHI AIR	CASABLANCA	AIR
10	Dec 2025	U L G	South Africa	Powder	20.0K	NOS	$0.033	$665.41	DELHI AIR	JOHANNESBURG - JOHAN	SEA
SUPPLIER #6 — 3S CORP · 1 shipments · $139.60
11	Nov 2025	FOR THE ORDER OF	Kenya	Injection	60	VLS	$2.33	$139.60	MUMBAI AIR (SAHAR)	NAIROBI	AIR
SUPPLIER #7 — MDS ENTERPRISES · 1 shipments · $9.81
12	Dec 2025	UNLISTED BUYER	Ghana	Injection	500	NOS	$0.020	$9.81	MUMBAI AIR (SAHAR)	ACCRA	AIR

10

PART VI — DRILL-DOWN · ASIA

Region: Asia

9 countries · 15 shipments · $253K · 10 Indian suppliers · 11 buyers

SHIPMENTS

15

USD

$253K

COUNTRIES

9

SUPPLIERS

10

BUYERS

11

HHI

5,216

concentrated

Top 9 destination countries in Asia

1

Saudi Arabia (59.2%)

$150K

2

Nepal (20.1%)

$51K

3

Hong Kong (11.2%)

$28K

4

Afghanistan (7.7%)

$20K

5

Bahrain (0.9%)

$2K

6

Turkey (0.8%)

$2K

7

Singapore (0.1%)

$204.10

8

Myanmar (0.0%)

$19.97

9

United Arab Emirates (0.0%)

$12.81

Top 10 Indian suppliers into Asia

1

VENUS REMEDIES LTD

$178K

2

ALKEM LABORATORIES LTD

$35K

3

M. J. BIOPHARM PVT LTD

$16K

4

INDUS PHARMA PVT LTD

$11K

5

RESCUERS LIFE SCIENCES LTD

$9K

6

MILTON LIFECARE PVT LTD

$2K

7

S. HIMATLAL HEALTHCARE LLP

$2K

8

JPC GLOBAL

$204.10

9

PANGENE BIOTECH LTD

$19.97

10

MDS ENTERPRISES

$12.81

Top 9 Asia importers

1

S T C · Saudi Arabia

$150K

2

PARTH PHARMA DISTRIBUTORS PVT LTD · Nepal

$35K

3

C P L · Hong Kong

$28K

4

S GENERIX PHARMA DISTRIBUTORS · Nepal

$16K

5

KHALIQ ZAZAI PVT LTD · Afghanistan

$11K

6

ETEMED MOSLEH LTD · Afghanistan

$9K

7

GULF PHARMACIES W.L.L · Bahrain

$2K

8

TO THE IMPORTING DEPARTMENT · Singapore

$204.10

9

OCTELLE CO LTD · Myanmar

$9.98

Top 3 dosage forms

1

Powder

$178K

2

Injection

$75K

3

Vial

$19.97

Monthly trend

Month	Ships	USD	Avg/ship
Oct	2	$18K	$9K
Nov	8	$188K	$23K
Dec	5	$48K	$10K

Shipment register · 15 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — VENUS REMEDIES LTD · 4 shipments · $178K
1	Nov 2025	S T C	Saudi Arabia	Powder	200	NOS	$1.46	$291.66	CMA CGM LOGISTICS ICD	DAMMAM	ICD
2	Nov 2025	S T C	Saudi Arabia	Powder	54.8K	NOS	$2.07	$114K	CMA CGM LOGISTICS ICD	DAMMAM	ICD
3	Nov 2025	S T C	Saudi Arabia	Powder	10.5K	NOS	$3.43	$36K	CMA CGM LOGISTICS ICD	DAMMAM	ICD
4	Dec 2025	C P L	Hong Kong	Powder	10.0K	NOS	$2.83	$28K	DELHI AIR	HONG KONG	AIR
SUPPLIER #2 — ALKEM LABORATORIES LTD · 2 shipments · $35K
5	Nov 2025	PARTH PHARMA DISTRIBUTORS PVT LTD	Nepal	Injection	70.5K	NOS	$0.415	$29K	RAXAUL	Birgunj	ROAD
6	Nov 2025	PARTH PHARMA DISTRIBUTORS PVT LTD	Nepal	Injection	31.0K	NOS	$0.191	$6K	RAXAUL	Birgunj	ROAD
SUPPLIER #3 — M. J. BIOPHARM PVT LTD · 1 shipments · $16K
7	Oct 2025	S GENERIX PHARMA DISTRIBUTORS	Nepal	Injection	7.1K	VLS	$2.21	$16K	RAXAUL	Kathmandu	ROAD
SUPPLIER #4 — INDUS PHARMA PVT LTD · 1 shipments · $11K
8	Dec 2025	KHALIQ ZAZAI PVT LTD	Afghanistan	Injection	5.0K	VLS	$2.19	$11K	REWARI ICD	KABUL	ICD
SUPPLIER #5 — RESCUERS LIFE SCIENCES LTD · 1 shipments · $9K
9	Dec 2025	ETEMED MOSLEH LTD	Afghanistan	Injection	5.0K	PCS	$1.71	$9K	LUDHIANA ICD	KABUL	ICD
SUPPLIER #6 — MILTON LIFECARE PVT LTD · 1 shipments · $2K
10	Nov 2025	GULF PHARMACIES W.L.L	Bahrain	Injection	400	VLS	$5.99	$2K	MUMBAI AIR (SAHAR)	BAHRAIN	AIR
SUPPLIER #7 — S. HIMATLAL HEALTHCARE LLP · 1 shipments · $2K
11	Oct 2025	UNLISTED BUYER	Turkey	Injection	1.0K	VLS	$1.97	$2K	NHAVA SHEVA SEA (JNPT)	Mersin	SEA
SUPPLIER #8 — JPC GLOBAL · 1 shipments · $204.10
12	Dec 2025	TO THE IMPORTING DEPARTMENT	Singapore	Injection	20	PCS	$10.21	$204.10	MUMBAI AIR (SAHAR)	SINGAPORE	AIR
SUPPLIER #9 — PANGENE BIOTECH LTD · 2 shipments · $19.97
13	Nov 2025	OCTELLE CO LTD	Myanmar	Vial	50	VLS	$0.200	$9.98	MUMBAI AIR (SAHAR)	YANGON	AIR
14	Nov 2025	UNKNOWN BUYER	Myanmar	Vial	50	VLS	$0.200	$9.98	MUMBAI AIR (SAHAR)	YANGON	AIR
SUPPLIER #10 — MDS ENTERPRISES · 1 shipments · $12.81
15	Dec 2025	UNLISTED BUYER	United Arab Emirates	Injection	500	NOS	$0.026	$12.81	MUMBAI AIR (SAHAR)	SHARJAH	AIR

10

PART VI — DRILL-DOWN · EUROPE

Region: Europe

5 countries · 10 shipments · $629K · 4 Indian suppliers · 5 buyers

SHIPMENTS

10

USD

$629K

COUNTRIES

5

SUPPLIERS

4

BUYERS

5

HHI

8,195

concentrated

Top 5 destination countries in Europe

1

Belgium (58.1%)

$365K

2

Netherlands (32.3%)

$203K

3

Albania (4.4%)

$28K

4

Hungary (3.8%)

$24K

5

Moldova (1.4%)

$9K

Top 4 Indian suppliers into Europe

1

SUN PHARMACEUTICAL INDUSTRIES LTD

$568K

2

NOVO MEDI SCIENCES PVT LTD

$28K

3

VENUS REMEDIES LTD

$24K

4

SWISS PARENTERALS LTD

$9K

Top 3 Europe importers

1

YUSEN LOGISTICS BENELUX BELGIUM · Belgium

$219K

2

I+SOLUTIONS · Netherlands

$203K

3

E P H K · Hungary

$24K

Top 3 dosage forms

1

Injection

$402K

2

Powder

$203K

3

Oral Solution

$24K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$28K	$28K
Nov	4	$220K	$55K
Dec	5	$382K	$76K

Shipment register · 10 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 7 shipments · $568K
1	Nov 2025	UNKNOWN BUYER	Belgium	Injection	1.9K	NOS	$16.46	$31K	DELHI AIR	BRUSSELS	AIR
2	Nov 2025	UNKNOWN BUYER	Belgium	Injection	5.9K	NOS	$19.70	$116K	DELHI AIR	BRUSSELS	AIR
3	Nov 2025	YUSEN LOGISTICS BENELUX BELGIUM	Belgium	Injection	18.0K	PCS	$2.73	$49K	DHANNAD ICD	ANTWERPEN	ICD
4	Dec 2025	I+SOLUTIONS	Netherlands	Powder	51.2K	VLS	$2.66	$136K	MUMBAI AIR (SAHAR)	AMSTERDAM, SCHIPHOL	AIR
5	Dec 2025	I+SOLUTIONS	Netherlands	Powder	25.0K	VLS	$2.67	$67K	MUMBAI AIR (SAHAR)	AMSTERDAM, SCHIPHOL	AIR
6	Dec 2025	YUSEN LOGISTICS BENELUX BELGIUM	Belgium	Injection	5.3K	PCS	$21.02	$111K	INDORE AIR	BRUSSELS	AIR
7	Dec 2025	YUSEN LOGISTICS BENELUX BELGIUM	Belgium	Injection	3.3K	PCS	$17.40	$58K	INDORE AIR	BRUSSELS	AIR
SUPPLIER #2 — NOVO MEDI SCIENCES PVT LTD · 1 shipments · $28K
8	Oct 2025	UNLISTED BUYER	Albania	Injection	10.0K	NOS	$2.76	$28K	NHAVA SHEVA SEA (JNPT)	DURRES	SEA
SUPPLIER #3 — VENUS REMEDIES LTD · 1 shipments · $24K
9	Nov 2025	E P H K	Hungary	Oral Solution	9.6K	NOS	$2.52	$24K	DELHI AIR	BUDAPEST,	AIR
SUPPLIER #4 — SWISS PARENTERALS LTD · 1 shipments · $9K
10	Dec 2025	UNLISTED BUYER	Moldova	Injection	4.0K	NOS	$2.25	$9K	AHMEDABAD AIR	CHISINAU	AIR

10

PART VI — DRILL-DOWN · AMERICAS

Region: Americas

5 countries · 8 shipments · $505K · 4 Indian suppliers · 6 buyers

SHIPMENTS

8

USD

$505K

COUNTRIES

5

SUPPLIERS

4

BUYERS

6

HHI

7,366

concentrated

Top 5 destination countries in Americas

1

Mexico (82.0%)

$414K

2

Bolivia (12.9%)

$65K

3

Jamaica (2.9%)

$14K

4

Dominican Republic (2.2%)

$11K

5

Brazil (0.0%)

$2.67

Top 4 Indian suppliers into Americas

1

VENUS REMEDIES LTD

$428K

2

KWALITY PHARMACEUTICALS LTD

$65K

3

FLAGSHIP BIOTECH INTERNATIONAL PVT LTD

$11K

4

SUN PHARMACEUTICAL INDUSTRIES LTD

$2.67

Top 5 Americas importers

1

L J S A D E C V · Mexico

$359K

2

LOBA IMPORT EXPORT SRL · Bolivia

$65K

3

L J S D C · Mexico

$54K

4

MEDICAL PRODUCTS LTD · Jamaica

$14K

5

RANBAXY FARMACEUTICA LTDA · Brazil

$2.67

Top 3 dosage forms

1

Injection

$501K

2

Solution

$4K

3

Suspension

$2.67

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$359K	$359K
Nov	3	$65K	$22K
Dec	4	$81K	$20K

Shipment register · 8 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — VENUS REMEDIES LTD · 5 shipments · $428K
1	Oct 2025	L J S A D E C V	Mexico	Injection	224.0K	VLS	$1.60	$359K	DADRI ICD	Lazaro Cardenas	ICD
2	Nov 2025	L J S D C	Mexico	Injection	31.0K	VLS	$1.62	$50K	CMA CGM LOGISTICS ICD	LAZARO CARDENAS	ICD
3	Nov 2025	MEDICAL PRODUCTS LTD	Jamaica	Injection	4.0K	NOS	$3.60	$14K	DELHI AIR	KINGSTON	AIR
4	Dec 2025	L J S D C	Mexico	Injection	13.3K	VLS	$0.018	$242.24	DELHI AIR	MEXICO CITY	AIR
5	Dec 2025	L J S D C	Mexico	Solution	216.7K	VLS	$0.018	$4K	DELHI AIR	MEXICO CITY	AIR
SUPPLIER #2 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $65K
6	Dec 2025	LOBA IMPORT EXPORT SRL	Bolivia	Injection	30.5K	NOS	$2.14	$65K	LUDHIANA ICD	SANTA CRUZ	ICD
SUPPLIER #3 — FLAGSHIP BIOTECH INTERNATIONAL PVT LTD · 1 shipments · $11K
7	Dec 2025	UNLISTED BUYER	Dominican Republic	Injection	6.0K	NOS	$1.89	$11K	MUMBAI AIR (SAHAR)	SANTO DOMINGO	AIR
SUPPLIER #4 — SUN PHARMACEUTICAL INDUSTRIES LTD · 1 shipments · $2.67
8	Nov 2025	RANBAXY FARMACEUTICA LTDA	Brazil	Suspension	338	PCS	$0.0079	$2.67	INDORE AIR	GUARULHOS	AIR

10

PART VI — EVIDENCE REGISTER

Indian Supplier Directory

All 19 Indian imipenem exporters — complete list ranked by USD

KEY TAKEAWAY This directory lists every Indian company that shipped imipenem in 2025-Q4.

S FOR SUPPLIERS

Find yourself and your competitors. Compare shipment count, USD, and destination regions.

B FOR BUYERS

Search for potential Indian suppliers. Filter by dosage form and destination region.

#	Supplier	City	Ships	USD	Dosage forms	Primary regions
1	VENUS REMEDIES LTD	Behra	14	$631K	Injection, Powder, Oral Solution	Americas, Asia
2	SUN PHARMACEUTICAL INDUSTRIES LTD	ANDHERI KURLA ROAD	10	$600K	Injection, Suspension, Vial	Europe, Americas
3	KWALITY PHARMACEUTICALS LTD	AMRITSAR	1	$65K	Injection	Americas
4	ALKEM LABORATORIES LTD	SILIGURI RAJGANJ	2	$35K	Injection	Asia
5	G S PHARMA PVT LTD	BANGALORE	1	$35K	Powder for Injection	Africa
6	NOVO MEDI SCIENCES PVT LTD	MUMBAI	1	$28K	Injection	Europe
7	CHETAN & DIPTI (C&D) PHARMA PVT LTD	MANDVI	2	$18K	Injection	Africa
8	M. J. BIOPHARM PVT LTD	MUMBAI	1	$16K	Injection	Asia
9	FLAGSHIP BIOTECH INTERNATIONAL PVT LTD	Kalyan	1	$11K	Injection	Americas
10	INDUS PHARMA PVT LTD	ALWAR	1	$11K	Injection	Asia
11	SWISS PARENTERALS LTD	AHMEDABAD	1	$9K	Injection	Europe
12	RESCUERS LIFE SCIENCES LTD	CHANDIGARH	1	$9K	Injection	Asia
13	MEDNEXT BIOTECH LTD	UDAIPUR	1	$2K	Injection	Africa
14	MILTON LIFECARE PVT LTD	MUMBAI	1	$2K	Injection	Asia
15	S. HIMATLAL HEALTHCARE LLP	MUMBAI	1	$2K	Injection	Asia
16	JPC GLOBAL	MUMBAI	1	$204.10	Injection	Asia
17	3S CORP	MUMBAI	1	$139.60	Injection	Africa
18	MDS ENTERPRISES	MUMBAI	2	$22.62	Injection	Africa, Asia
19	PANGENE BIOTECH LTD	KOLKATA	2	$19.97	Vial	Asia

10

PART VI — EVIDENCE REGISTER

Global Buyer Directory

All 24 global imipenem importers — complete list ranked by USD

KEY TAKEAWAY This directory lists every company that imported Indian imipenem in 2025-Q4.

S FOR SUPPLIERS

Search for potential customers by country and dosage form.

B FOR BUYERS

Find your company and see which Indian supplier serves you.

#	Buyer	Country	Ships	USD	Primary supplier	Dosage forms
1	L J S A D E C V	Mexico	1	$359K	VENUS REMEDIES LTD	Injection
2	YUSEN LOGISTICS BENELUX BELGIUM	Belgium	3	$219K	SUN PHARMACEUTICAL I…	Injection
3	I+SOLUTIONS	Netherlands	2	$203K	SUN PHARMACEUTICAL I…	Powder
4	S T C	Saudi Arabia	3	$150K	VENUS REMEDIES LTD	Powder
5	LOBA IMPORT EXPORT SRL	Bolivia	1	$65K	KWALITY PHARMACEUTIC…	Injection
6	L J S D C	Mexico	3	$54K	VENUS REMEDIES LTD	Injection, Solution
7	PARTH PHARMA DISTRIBUTORS PVT LTD	Nepal	2	$35K	ALKEM LABORATORIES LTD	Injection
8	LA COOPERATION PHARMACEUTIQUEMALGAC	Madagascar	1	$35K	G S PHARMA PVT LTD	Powder for Injection
9	C P L	Hong Kong	1	$28K	VENUS REMEDIES LTD	Powder
10	E P H K	Hungary	1	$24K	VENUS REMEDIES LTD	Oral Solution
11	KAMCARE PHARMA LTD	Uganda	2	$18K	CHETAN & DIPTI (C&D)…	Injection
12	RANBAXY PHARMACEUTICALS PTY LTD	South Africa	1	$18K	SUN PHARMACEUTICAL I…	Injection
13	S GENERIX PHARMA DISTRIBUTORS	Nepal	1	$16K	M. J. BIOPHARM PVT LTD	Injection
14	MEDICAL PRODUCTS LTD	Jamaica	1	$14K	VENUS REMEDIES LTD	Injection
15	KHALIQ ZAZAI PVT LTD	Afghanistan	1	$11K	INDUS PHARMA PVT LTD	Injection
16	ETEMED MOSLEH LTD	Afghanistan	1	$9K	RESCUERS LIFE SCIENC…	Injection
17	OFFICE PHARMACEUTIQUE NATIONALE	Gabon	1	$2K	MEDNEXT BIOTECH LTD	Injection
18	GULF PHARMACIES W.L.L	Bahrain	1	$2K	MILTON LIFECARE PVT …	Injection
19	U L G	South Africa	1	$665.41	VENUS REMEDIES LTD	Powder
20	TO THE IMPORTING DEPARTMENT	Singapore	1	$204.10	JPC GLOBAL	Injection
21	FOR THE ORDER OF	Kenya	1	$139.60	3S CORP	Injection
22	OCTELLE CO LTD	Myanmar	1	$9.98	PANGENE BIOTECH LTD	Vial
23	PHARMAPROM	Morocco	2	$4.57	VENUS REMEDIES LTD	Injection
24	RANBAXY FARMACEUTICA LTDA	Brazil	1	$2.67	SUN PHARMACEUTICAL I…	Suspension

This report covers 45 2025-Q4 Imipenem shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/imipenem

Talk to our trade analyst

Need a custom imipenem report or a deeper dive into any market? Our team is ready.

WhatsApp: +91 95950 78788 · transdatanexus.com

PHARMA TRADE INTELLIGENCE

Thank you for reading

This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.

Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.

Need a custom report?

We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.

Want deeper analysis?

Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.

Scan for product page

WhatsApp: +91 95950 78788

Email: info@transdatanexus.com

Web: https://transdatanexus.com/pharmaceutical/imipenem

© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only. Data sourced from official customs filings and licensed commercial trade databases. Reproduction without permission is prohibited.

Imipenem — Export Intelligence Report

Imipenem

§2.1 Reporting parameters · the scope of this 2025-Q4 Imipenem India trade report

§2.2 Our quality process · Figure 2.1

§2.3 Trust signals · what you can rely on in the numbers you read

§2.4 Limitations · what the data does and does not tell you

§3.1 Monthly summary

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

§4.2 Destination concentration

Product variety — how many formulations each supplier ships

§5.1 Supplier concentration metrics

§5.2 Coming next: 2 exporter deep-dive profiles

VENUS REMEDIES LTD

VENUS REMEDIES LTD — Supplier → Country → Importer

SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

§6.2 Single-source lock-in by country

§6.3 Price positioning — top 24 importers

§7.1 Price distribution · Table 7.1

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

§8.1 Reference transit times for key India → global corridors

§9.1 Single-source dependencies

§9.2 Multi-source resilience

§9.3 Sourcing recommendations · Table 9.1

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

§10.1 Global totals

§10.2 Regional breakdown

§10.3 Key insights from the data

§10.4 How to read a country page

Top 7 destination countries in Africa

Top 7 Indian suppliers into Africa

Top 7 Africa importers

Top 5 dosage forms

Monthly trend

Shipment register · 12 rows · grouped by exporter

Top 9 destination countries in Asia

Top 10 Indian suppliers into Asia

Top 9 Asia importers

Top 3 dosage forms

Monthly trend

Shipment register · 15 rows · grouped by exporter

Top 5 destination countries in Europe

Top 4 Indian suppliers into Europe

Top 3 Europe importers

Top 3 dosage forms

Monthly trend

Shipment register · 10 rows · grouped by exporter

Top 5 destination countries in Americas

Top 4 Indian suppliers into Americas

Top 5 Americas importers

Top 3 dosage forms

Monthly trend

Shipment register · 8 rows · grouped by exporter

Thank you for reading